Clinical stage pharmaceutical firm Iterum Therapeutics Plc (NASDAQ:ITRM) did not have a particularly great time in the capital markets this past Friday and its stock ended the day with a decline of as much as 4%.
Trading Data
On Friday, ITRM stock fell 4% at $0.5640 with more than 3.57 million million shares, compared to its average volume of 5.43 million shares. The stock has moved within a range of $0.5500 – 0.5901 after opening the trade at $0.5833.
Latest News
This past Friday, the company was also in the news after it announced that it was going to release its financial results for the fiscal third quarter on November 12, 2021. The company is going to announce its financial results prior to the opening of the markets on the day. However, the news was not welcomed with any kind of enthusiasm by investors and the stock ended up declining.
It is going to be interesting to see if the Iterum Therapeutics stock can actually manage to make a recover today or through the rest of the week. In this regard, it is also necessary to point out that the company also announced that it would be hosting a conference call with regards to the financial results at 8.30 a.m.
Eastern Time on the same day. In addition to a discussion with regards to the financial results, the company will also provide business updates during the conference call.
Technical Data
ITRM stock is trading below the 20-Day and 50-Day Moving averages of $0.57 and $0.59 respectively. Moreover, the stock is trading below 200-Day moving average of $1.18. The stock is down 27% in the past 3-month.
